{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:31:34Z","timestamp":1785803494325,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The coronavirus disease 2019 pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although the predominant clinical presentation is a respiratory disease, neurologic manifestations are being recognized increasingly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Report:<\/jats:title>\n            <jats:p>We report 2 children 9 years of age who developed acute disseminated encephalomyelitis-like disease associated with SARS-CoV-2. Seizures and encephalopathy were the main central nervous system symptoms. The cerebrospinal fluid analysis performed within the first week of disease onset showed elevated protein in both children with normal cell count and no evidence of infection including negative SARS-CoV-2 by antibody and polymerase chain reaction. Brain magnetic resonance imaging revealed T2A, fluid-attenuated inversion recovery cortical and subcortical hyperintensity without restricted diffusion consistent with acute disseminated encephalomyelitis\u2013like disease. They received methylprednisolone followed by therapeutic plasma exchange. One of them showed complete clinical improvement and resolution in magnetic resonance imaging findings. The other developed laminar necrosis in brain magnetic resonance imaging and showed significant clinical improvement after therapeutic plasma exchange. He was positive for positive SARS-CoV-2 antibody in cerebrospinal fluid on day 55 of admission. They were both positive for SARS-CoV-2 antibodies in serum after 2 weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our two cases highlight the occurrence of acute disseminated encephalomyelitis\u2013like disease as a postinfectious\/immune-mediated complication of SARS-CoV-2 infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003295","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T15:30:22Z","timestamp":1628868622000},"page":"e445-e450","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["COVID-19\u2013associated Acute Disseminated Encephalomyelitis\u2013like Disease in 2 Children"],"prefix":"10.1097","volume":"40","author":[{"given":"Nihal","family":"Ak\u00e7ay","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Bekta\u015f","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Emin","family":"Menento\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"O\u011fur","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe \u0130rem","family":"Sofuo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen Bakirta\u015f","family":"Palabiyik","sequence":"additional","affiliation":[{"name":"Department of Pediatric Radiology, Bak\u0131rk\u00f6y Dr. Sadi Konuk Research and Training Hospital, University of Health Sciences, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"\u015eevketo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019.","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"135567","DOI":"10.1016\/j.neulet.2020.135567","article-title":"Neurological issues in children with COVID-19.","volume":"743","author":"Lin","year":"2021","journal-title":"Neurosci Lett"},{"issue":"9 suppl 2","key":"R3-20250615","first-page":"S38","article-title":"Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome.","volume":"87","author":"Pohl","year":"2016","journal-title":"Neurology"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11910-005-0031-2","article-title":"Post-infectious encephalomyelitis.","volume":"5","author":"Mihai","year":"2005","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2352-4642(20)30362-X","article-title":"Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.","volume":"5","author":"Lindan","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R6-20250615","first-page":"jiab153","article-title":"Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms [published online ahead of print March 21, 2021].","author":"Cunningham","journal-title":"J Infect Dis"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3174\/ajnr.A1184","article-title":"Susceptibility-weighted imaging findings of cortical laminar necrosis in pediatric patients.","volume":"29","author":"Niwa","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/ccr3.2936","article-title":"Cortical laminar necrosis in an infant with influenza A virus infection.","volume":"8","author":"Yaginuma","year":"2020","journal-title":"Clin Case Rep"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12883-017-0855-9","article-title":"Cortical laminar necrosis in dengue encephalitis-a case report.","volume":"17","author":"Garg","year":"2017","journal-title":"BMC Neurol"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1096\/fj.202001115R","article-title":"Genetic gateways to COVID-19 infection: implications for risk, severity, and outcomes.","volume":"34","author":"Debnath","year":"2020","journal-title":"FASEB J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003295","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:35Z","timestamp":1750003415000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003295","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,12]]}}}